Literature DB >> 8264596

The transcription factor E2F-1 mediates the autoregulation of RB gene expression.

B Shan1, C Y Chang, D Jones, W H Lee.   

Abstract

The retinoblastoma (RB) gene is the prototype tumor suppressor gene. Mutations in this gene are often associated with the occurrence of various tumors. Several mutations have been found in the promoter region of the gene, suggesting that inappropriate transcriptional regulation of the RB gene contributes to tumorigenesis. Sequence analysis of the RB promoter has revealed a potential E2F recognition site within a region critical for RB gene transcription. By using the cloned E2F-1 gene, here we report that (i) RB expression is negatively regulated by its own gene product, (ii) E2F-1 binds specifically to an E2F recognition sequence in the RB promoter and transactivates the RB promoter, (iii) overexpression of RB suppresses E2F-1-mediated stimulation of RB promoter activity, and (iv) the expression of the RB gene is paralleled by the expression of the E2F-1 gene during cell cycle progression. These results demonstrate that expression of RB is negatively autoregulated through E2F-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8264596      PMCID: PMC358379          DOI: 10.1128/mcb.14.1.299-309.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  57 in total

1.  Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F.

Authors:  B Shan; X Zhu; P L Chen; T Durfee; Y Yang; D Sharp; W H Lee
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

2.  Identification of a growth suppression domain within the retinoblastoma gene product.

Authors:  X Q Qin; T Chittenden; D M Livingston; W G Kaelin
Journal:  Genes Dev       Date:  1992-06       Impact factor: 11.361

3.  A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F.

Authors:  K Helin; J A Lees; M Vidal; N Dyson; E Harlow; A Fattaey
Journal:  Cell       Date:  1992-07-24       Impact factor: 41.582

4.  Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers.

Authors:  T W Hai; F Liu; W J Coukos; M R Green
Journal:  Genes Dev       Date:  1989-12       Impact factor: 11.361

5.  The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit.

Authors:  T Durfee; K Becherer; P L Chen; S H Yeh; Y Yang; A E Kilburn; W H Lee; S J Elledge
Journal:  Genes Dev       Date:  1993-04       Impact factor: 11.361

6.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

7.  Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins.

Authors:  H Matsushime; M E Ewen; D K Strom; J Y Kato; S K Hanks; M F Roussel; C J Sherr
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

8.  Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product.

Authors:  A K Rustgi; N Dyson; R Bernards
Journal:  Nature       Date:  1991-08-08       Impact factor: 49.962

9.  Differentiation of Y79 retinoblastoma cells induced by succinylated concanavalin A.

Authors:  G M Seigel; M F Notter
Journal:  Cell Growth Differ       Date:  1993-01

10.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2.

Authors:  J A Lees; K J Buchkovich; D R Marshak; C W Anderson; E Harlow
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  45 in total

Review 1.  Tossing monkey wrenches into the clock: new ways of treating cancer.

Authors:  J A Lees; R A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 2.  Integration of the pRB and p53 cell cycle control pathways.

Authors:  C L Stewart; A M Soria; P A Hamel
Journal:  J Neurooncol       Date:  2001-02       Impact factor: 4.130

3.  Sequence-specific transcriptional repression by an MBD2-interacting zinc finger protein MIZF.

Authors:  Masayuki Sekimata; Yoshimi Homma
Journal:  Nucleic Acids Res       Date:  2004-01-29       Impact factor: 16.971

4.  Rb/E2F regulates expression of neogenin during neuronal migration.

Authors:  Matthew G Andrusiak; Kelly A McClellan; Delphie Dugal-Tessier; Lisa M Julian; Sonia P Rodrigues; David S Park; Timothy E Kennedy; Ruth S Slack
Journal:  Mol Cell Biol       Date:  2010-11-08       Impact factor: 4.272

5.  Transcriptional upregulation of p57 (Kip2) by the cyclin-dependent kinase inhibitor BMS-387032 is E2F dependent and serves as a negative feedback loop limiting cytotoxicity.

Authors:  Y Ma; W D Cress
Journal:  Oncogene       Date:  2006-12-18       Impact factor: 9.867

6.  Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo.

Authors:  Y Maeshima; N Kashihara; T Yasuda; H Sugiyama; T Sekikawa; K Okamoto; K Kanao; Y Watanabe; Y S Kanwar; H Makino
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry.

Authors:  K Moberg; M A Starz; J A Lees
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

8.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

Review 9.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

10.  Positive autoregulation of the glial promoting factor glide/gcm.

Authors:  A A Miller; R Bernardoni; A Giangrande
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.